A 28% reduction in hospital admissions leads to a broader agreement, the physicians' group and payer say.
Florida Cancer Specialists and Research Initiative (FCS) and the insurer Cigna are expanding their collaboration for value-based cancer care. Since 2015, FCS has provided services to Cigna patients through a collaborative care arrangement that included extra support, education, and efforts to reduce hospitalization and unnecessary visits to the emergency department.
Those efforts were initially offered to patients with breast, lung, and colorectal cancers, leukemia, and lymphoma and resulted in a 28% lower inpatient admission rate compared with patients outside the value-based model. So now, the collaboration will involve patients with all cancer diagnoses and provide additional treatment therapies.
For more, see the full press release here.
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Stagnation in Reimbursement Keeps Biomedical Innovation From Reaching All Patients, COA Panel Says
September 9th 2025Panelists at the Community Oncology Alliance Payer Exchange Summit discuss the urgent need for innovative reimbursement models in cancer care to match advancements in biomedical technology and drug discovery.
Read More
Current and Emerging Options for Uncommon EGFR- and Exon 20 Insertion–Mutated NSCLC
September 8th 2025Uncommon EGFR mutations in non–small cell lung cancer (NSCLC) remain challenging to treat, but new tyrosine kinase inhibitors, bispecific antibodies, and a proposed “PACCage insert” framework provide opportunities to advance precision therapy.
Read More